Phase 3Completed
A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)
A Multicenter, Randomized, Double-Blind, Parallel, 12-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Elderly Patients With Hypercholesterolemia at High or Moderately High Risk for Coronary Heart Disease
- Sponsor
- Organon and Co (Industry)
- Enrollment
- 1,289 enrolled
- Conditions
- Hypercholesterolemia
- Interventions
- Atorvastatin 10 mg; Ezetimibe 10 mg/simvastatin 20 mg; Atorvastatin 20 mg; Ezetimibe 10 mg/simvastatin 40 mg; Atorvastatin 40 mg
- Ages
- older adults
- Registry
- NCT00535405
Full record on ClinicalTrials.gov
From the registry
A multicenter study to evaluate the safety and efficacy of ezetimibe/simvastatin versus atorvastatin in elderly patients with high cholesterol at high or moderately high risk for coronary heart disease.
Primary outcomes
- Percent Change From Baseline in Low Density Lipoprotein (LDL-C) at Week 12
History
Last registry update
Results first posted
Primary completion
Started
Registered